American Heart Journal

1

An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration

Matt Fisher, Mary Cushman, Volker Knappertz, George Howard

Journal:

Year:

2008

Language:

english

File:

PDF, 177 KB

english, 2008

2

Factors that influence the use of ambulance in acute coronary syndrome

Marie Thuresson, Marianne Berglin Jarlöv, Bertil Lindahl, Leif Svensson, Crister Zedigh, Johan Herlitz

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 137 KB

english, 2008

3

Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy

Sharie B. Parks, Jessica D. Kushner, Deirdre Nauman, Donna Burgess, Susan Ludwigsen, Amanda Peterson, Duanxiang Li, Petra Jakobs, Michael Litt, Charles B. Porter, Peter S. Rahko, Ray E. Hershberger

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 753 KB

english, 2008

4

Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: A prospective randomized trial

Chia-Ti Tsai, Ling-Ping Lai, Juey-Jen Hwang, Yi-Chih Wang, Fu-Tien Chiang, Jiunn-Lee Lin

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 206 KB

english, 2008

5

Safety and effectiveness of drug-eluting stents among diabetic patients: A propensity analysis

Dennis T. Ko, Maria Chiu, Peter C. Austin, James Bowen, Eric A. Cohen, Jack V. Tu

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 648 KB

english, 2008

6

Impact of do-not-resuscitation orders on quality of care performance measures in patients hospitalized with acute heart failure

Joline L.T. Chen, Jonathan Sosnov, Darleen Lessard, Robert J. Goldberg

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 129 KB

english, 2008

7

Patterns of transfer for patients with non–ST-segment elevation acute coronary syndrome from community to tertiary care hospitals

Matthew T. Roe, Anita Y. Chen, Elizabeth R. Delong, William E. Boden, James E. Calvin Jr, Charles B. Cairns, Sidney C. Smith Jr, Charles V. Pollack Jr, Ralph G. Brindis, Robert M. Califf, W. Brian Gib

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 190 KB

english, 2008

8

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

Vanessa Roldán, Francisco Marín, Juan R. Gimeno, Francisco Ruiz-Espejo, Josefa González, Eloisa Feliu, Antonio García-Honrubia, Daniel Saura, Gonzalo de la Morena, Mariano Valdés, Vicente Vicente

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 269 KB

english, 2008

9

Smoking status and antithrombin therapy in patients with non–ST-segment elevation acute coronary syndrome

Steve Leung, Dianne Gallup, Kenneth W. Mahaffey, Marc Cohen, Elliott M. Antman, Shaun G. Goodman, Robert A. Harrington, Anatoly Langer, Philip Aylward, James J. Ferguson, Robert M. Califf

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 142 KB

english, 2008

10

Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention

Christopher B. Overgaard, Joan Ivanov, Peter H. Seidelin, Mina Todorov, Karen Mackie, Vladimír Džavík

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 202 KB

english, 2008

11

Exercise capacity and biventricular function in adult patients with repaired tetralogy of Fallot

Ahmed Samman, Markus Schwerzmann, Olga H. Balint, David Tanous, Andrew Redington, John Granton, Samuel C. Siu, Candice K. Silversides

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 141 KB

english, 2008

12

One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study

Olivier F. Bertrand, Josep Rodés-Cabau, Éric Larose, Can Manh Nguyen, Louis Roy, Jean-Pierre Déry, Javier Courtis, Isabelle Nault, Paul Poirier, Olivier Costerousse, Robert De Larochellière

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 269 KB

english, 2008

13

The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale

Roxana Mehran, Bruce Brodie, David A. Cox, Cindy L. Grines, Barry Rutherford, Deepak L. Bhatt, George Dangas, Fred Feit, E. Magnus Ohman, Helen Parise, Martin Fahy, Alexandra J. Lansky, Gregg W. Stone

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 358 KB

english, 2008

14

Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial

Lyne Lalonde, Josée Martineau, Normand Blais, Martine Montigny, Jeffrey Ginsberg, Martine Fournier, Djamal Berbiche, Marie-Claude Vanier, Lucie Blais, Sylvie Perreault, Isabel Rodrigues

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 270 KB

english, 2008

15

Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome

Boris Bigalke, Tobias Geisler, Konstantinos Stellos, Harald Langer, Karin Daub, Elisabeth Kremmer, Peter Seizer, Andreas E. May, Stephan Lindemann, Meinrad Gawaz

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 503 KB

english, 2008

16

Correlates of late and very late thrombosis of drug eluting stents

Gregory J. Mishkel, Anna L. Moore, Steve Markwell, Marc E. Shelton

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 199 KB

english, 2008

17

Body mass index and mortality in heart failure: A meta-analysis

Antigone Oreopoulos, Raj Padwal, Kamyar Kalantar-Zadeh, Gregg C. Fonarow, Colleen M. Norris, Finlay A. McAlister

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 612 KB

english, 2008

18

Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy

Martin Landsberger, Alexander Staudt, Sangita Choudhury, Christiane Trimpert, Lars R. Herda, Karin Klingel, Reinhard Kandolf, Heinz-Peter Schultheiss, Heyo K. Kroemer, Uwe Völker, Stephan B. Felix

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 377 KB

english, 2008

19

Do specialty cardiac hospitals have greater adherence to acute myocardial infarction and heart failure process measures? An empirical assessment using Medicare quality measures: Quality of care in cardiac specialty hospitals

Ioana Popescu, Brahmajee K. Nallamothu, Mary S. Vaughan-Sarrazin, Peter Cram

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 184 KB

english, 2008

20

Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities

Gregory Y.H. Lip

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 79 KB

english, 2008

21

N-terminal pro–brain natriuretic peptide testing in the emergency department: Beneficial effects on hospitalization, costs, and outcome

Joost H.W. Rutten, Ewout W. Steyerberg, Frans Boomsma, Jan L.C.M. van Saase, Jaap W. Deckers, Henk C. Hoogsteden, Jan Lindemans, Anton H. van den Meiracker

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 253 KB

english, 2008

22

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone

Adrian V. Hernandez, Esteban Walker, John P.A. Ioannidis, Michael W. Kattan

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 191 KB

english, 2008

23

Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004

Heli Ghandehari, Sachin Kamal-Bahl, Nathan D. Wong

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 333 KB

english, 2008

24

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme

Stephan Rietbrock, Emma Heeley, Jonathan Plumb, Tjeerd van Staa

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 214 KB

english, 2008

25

Evaluating diagnostic tests—should the same methods apply?

Jenny A. Doust, Jonathon C. Craig

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 79 KB

english, 2008

26

Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapies

Niteesh K. Choudhry, Troyen Brennan, Michele Toscano, Claire Spettell, Robert J. Glynn, Mark Rubino, Sebastian Schneeweiss, Alan M. Brookhart, Joaquim Fernandes, Susan Mathew, Blake Christiansen, Elli

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 129 KB

english, 2008

27

Recovery of normal ventricular function in patients with dilated cardiomyopathy: Relevance of the etiology

Pasquale Santangeli, Francesca Marzo, Andrea Macchione, Fulvio Bellocci, Filippo Crea, Maurizio Pieroni

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 48 KB

english, 2008

28

Obesity and postoperative atrial fibrillation. Is there no connection?: Comment on: Wanahita et al. “Atrial fibrillation and obesity—results of a meta-analysis”

Maciej Banach, Jan Henryk Goch, Murat Ugurlucan, Jacek Rysz, Dimitri P. Mikhailidis

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 56 KB

english, 2008

29

Should an angiotensin-converting enzyme inhibitor be given at the time of reperfusion therapy in acute myocardial infarction?

Craig Steven McLachlan, Ryan Ocsan, Brett Hambly, Reida El Oakley

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 56 KB

english, 2008

30

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

Jose Antonio Marin-Neto, Anis Rassi Jr, Carlos A. Morillo, Alvaro Avezum, Stuart J. Connolly, Sergio Sosa-Estani, Fernando Rosas, Salim Yusuf

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 142 KB

english, 2008

31

Late-breaking trials summary from the 2008 American College of Cardiology Scientific Sessions, March 29 to April 1, Chicago, IL

Renato D. Lopes, Mark Chan, Chiara Melloni, E. Marc Jolicoeur, Larry A. Allen, Bimal R. Shah, Jason N. Katz, Jeffrey S. Berger, Jonathan P. Piccini

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 106 KB

english, 2008

32

Editorial Board

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 33 KB

english, 2008

34

Information for Authors

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 68 KB

english, 2008

35

Information for Readers

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 44 KB

english, 2008

Volume 156; Issue 1

An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration

Factors that influence the use of ambulance in acute coronary syndrome

Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy

Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: A prospective randomized trial

Safety and effectiveness of drug-eluting stents among diabetic patients: A propensity analysis

Impact of do-not-resuscitation orders on quality of care performance measures in patients hospitalized with acute heart failure

Patterns of transfer for patients with non–ST-segment elevation acute coronary syndrome from community to tertiary care hospitals

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

Smoking status and antithrombin therapy in patients with non–ST-segment elevation acute coronary syndrome

Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention

Exercise capacity and biventricular function in adult patients with repaired tetralogy of Fallot

One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study

The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale

Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial

Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome

Correlates of late and very late thrombosis of drug eluting stents

Body mass index and mortality in heart failure: A meta-analysis

Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy

Do specialty cardiac hospitals have greater adherence to acute myocardial infarction and heart failure process measures? An empirical assessment using Medicare quality measures: Quality of care in cardiac specialty hospitals

Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities

N-terminal pro–brain natriuretic peptide testing in the emergency department: Beneficial effects on hospitalization, costs, and outcome

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone

Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme

Evaluating diagnostic tests—should the same methods apply?

Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapies

Recovery of normal ventricular function in patients with dilated cardiomyopathy: Relevance of the etiology

Obesity and postoperative atrial fibrillation. Is there no connection?: Comment on: Wanahita et al. “Atrial fibrillation and obesity—results of a meta-analysis”

Should an angiotensin-converting enzyme inhibitor be given at the time of reperfusion therapy in acute myocardial infarction?

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

Late-breaking trials summary from the 2008 American College of Cardiology Scientific Sessions, March 29 to April 1, Chicago, IL

Table of Contents

Editorial Board

Information for Authors

Information for Readers